Genetics of PICALM expression and Alzheimer's disease.
Novel Alzheimer's disease (AD) risk factors have been identified by genome-wide association studies. Elucidating the mechanism underlying these factors is critical to the validation process and, by identifying rate-limiting steps in AD risk, may yield novel therapeutic targets. Here, we evaluat...
Guardado en:
Autores principales: | Ishita Parikh, David W Fardo, Steven Estus |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/539952d6005c419a81a4841fa17cbc73 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genetics of clusterin isoform expression and Alzheimer's disease risk.
por: I-Fang Ling, et al.
Publicado: (2012) -
An exploratory study on CLU, CR1 and PICALM and Parkinson disease.
por: Jianjun Gao, et al.
Publicado: (2011) -
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.
por: Lesley Jones, et al.
Publicado: (2010) -
Lack of genetic support for shared aetiology of Coronary Artery Disease and Late-onset Alzheimer’s disease
por: Christopher Grace, et al.
Publicado: (2018) -
Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer’s disease
por: Atul Kumar, et al.
Publicado: (2021)